VPPN Market Intelligence Series: Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy

Market Intelligence Series: Webinar 3 - How can market intelligence help with understanding vaccine markets to inform a procurement strategy?

Register for the webinar here

Dear TechNet members,

UNICEF's Vaccine Procurement Practitioners Network (VPPN) will conclude its series on the theme of market intelligence with a third and final webinar that will take place on Thursday, 5 December 2024, from 1pm to 2pm GMT+1, in English, Russian and French, and to which you are most welcome.

This webinar will focus on how market intelligence can help with understanding vaccine markets to inform a procurement strategy, through one presentation and two case studies highlighting product switches.

Johns Hopkins Bloomberg School of Public Health's Molly Sauer will start by explaining how to use market intelligence to inform procurement decisions, including what considerations to take when changing the procurement strategy, what steps allow the decision to be made and what stakeholders should be involved. Then, Aleksandra Grozdanova, President of the North Macedonian National Committee for immunization, will present the current switch to the nine-valent HPV vaccine in North Macedonia, while Tursunova Diloram Alimovna, Head of the Uzbek Department of Vaccine Logistics and Immunoprophylaxis, will talk about the switch to the liquid Rota vaccine in Uzbekistan.

To take part in the webinar, you need to register here. Please, note that registration is compulsory.
Once registered, you will receive an e-mail confirmation with the Zoom link to the webinar.

What market intelligence resources do YOU use for your procurement decisions? Are you familiar with UNICEF's Vaccine Market Dashboard? Of the information presented in the dashboard (products, prices, deliveries, approvals), which one do you find most relevant, and are there any additional features that would make it more useful for you?

We would like to hear more from you! So please, do share with us your feedback to the above questions or any other question or challenge you might face. A 15-minute Q&A session will be included in the webinar, and our panellists and experts will be happy to answer you with their experience and insight.

You can access all resources from the previous webinars in the series, including our Q&A document "How to leverage market intelligence for your vaccine procurement strategy – Discussion with Estonia, Georgia, North Macedonia and Uzbekistan", by clicking the following links:

• Webinar 1 - "What is market intelligence and how to build it?: webinar recording + other resources
• Webinar 2 - "How to leverage market intelligence for national decision-making and vaccine product choice?" : webinar recording + other resources

We are looking forward to welcoming you during this event. And in the meantime, you can reach me, through the platform or by email at [email protected], for any request or question you might have.
 
Kind regards,
 
Dyuti

*****

Objectives

• Discuss the role of market intelligence with regard to understanding vaccine markets and national decision-making
• Share concrete examples of how to use market intelligence for vaccine switches
• Provide peer-to-peer learning through South-South Cooperation as well as expert knowledge to support countries accessing quality-assured vaccines
• Answer questions on the topic

Speakers

• Molly Sauer, Project Director, Choice Optimization for Immunization: Country Exercises in Sustainability (CHOICES), Johns Hopkins Bloomberg School of Public Health
• Aleksandra Grozdanova, President of the National Committee for immunization, North Macedonia
• Tursunova Diloram Alimovna, Head of the Department of Vaccine Logistics and Immunoprophylaxis, Ministry of Health, Uzbekistan

Moderator

• Alexei Ceban, Immunization Specialist, Europe and Central Asia Region, UNICEF

Agenda

    1:00pm GMT+1    Welcome and introduction of the topic
    1:02pm GMT+1    Johns Hopkins Bloomberg School of Public Health's presentation
    1:12pm GMT+1    North Macedonia's presentation
    1:27pm GMT+1    Uzbekistan's presentation
    1:42pm GMT+1    Questions & Answers
    1:57pm GMT+1    Closing remarks
    2:00pm GMT+1    End & Further E-discussion on the VPPN